Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
暂无分享，去创建一个
M. Suchard | M. Schuemie | G. Hripcsak | A. Nishimura | A. Ostropolets | T. Duarte-Salles | W. Lau | M. Bowring | T. Falconer | S. Seager | Jianxiao Yang | N. Mathioudakis | C. Blacketer | J. Posada | A. Pistillo | Yuntian Liu | A. Aminorroaya | E. Minty | Fan Bu | Can Yin | M. Matheny | F. Arshad | L. Dhingra | E. Hanchrow | M. McLemore | N. Pratt | Carlen Reyes | S. C. You | Arya Aminorroaya | Michael Cook | David A Dorr | Tina E French | Jing Li | Kelly Li | Kenneth Kc Man | Paul Nagy | Joseph S. Ross | Katherine R Simon | Jin J Zhou | Patrick B. Ryan | Harlan Krumholz | Nigam H. Shah | Rohan Khera | Scott L. DuVall | S. Horban | Daniel R Morales | Yuan Lu | Eric YF Wan | A. Aminorroaya | Eric Y F Wan | Katherine R. Simon